Shannon Thyme Klinger, Chief Legal Officer at Moderna, Inc. (MRNA), sold 18,722 shares at $52.29 ($976K) on 2026-03-02, disclosed to the SEC on 2026-03-03.
Seasonal sale ($976k) by Chief Legal Officer — this insider has traded MRNA in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $51.71 | 113 | $6K | 0.6% |
| 2 | $51.71 | 160 | $8K | 0.8% |
| 3 | $51.71 | 375 | $19K | 2.0% |
| 4 | $51.71 | 4,189 | $217K | 22.2% |
| 5 | $52.29 | 13,885 | $726K | 74.4% |
| Total | $52.14 avg | 18,722 |
| $976K |
| 100% |
| Filing → |
| MRNA | SELL | 2024-12-10 | $24K | — | Filing → |
| MRNA | SELL | 2024-12-04 | $5K | — | Filing → |
| MRNA | SELL | 2024-12-02 | $121K | — | Filing → |